RGC-32 as a potential biomarker of relapse and response to treatment with glatiramer acetate in multiple sclerosis

Currently there is critical need for the identification of reliable biomarkers to help guide clinical management of multiple sclerosis (MS) patients. We investigated the combined roles of Response Gene to Complement 32 (RGC-32), FasL, CDC2, AKT, and IL-21 as possible biomarkers of relapse and respon...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Exp Mol Pathol
Main Authors: Kruszewski, Adam M., Rao, Gautam, Tatomir, Alexandru, Hewes, Daniel, Tegla, Cosmin A., Cudrici, Cornelia D., Nguyen, Vingh, Royal, Walter, Bever, Christopher T., Rus, Violeta, Rus, Horea
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6594183/
https://ncbi.nlm.nih.gov/pubmed/26407760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.yexmp.2015.09.007
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados